Not applicableLooking for participantsNCT07255859What this trial is testingAVIGA3 (Cohort 2.0)Who this might be right forMaculopathy Tan Tock Seng Hospital 60
Post-approval studies (Phase 4)Study completedNCT00135837What this trial is testingPhotodynamic Therapy in Occult-Only Lesions (POOL)Who this might be right forAge-Related Macular Degeneration Novartis 202
Early research (Phase 1)Study completedNCT00018070What this trial is testingIdentification and Treatment of Feeder Vessels in Macular DegenerationWho this might be right forMacular Degeneration National Eye Institute (NEI) 20
Large-scale testing (Phase 3)Looking for participantsNCT07440225What this trial is testingA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)Who this might be right forMacular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more EyeBiotech Ltd. 960
Early research (Phase 1)Study completedNCT00001615What this trial is testingPhase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular DegenerationWho this might be right forChoroidal NeovascularizationMacular Degeneration National Eye Institute (NEI) 180
Post-approval studies (Phase 4)UnknownNCT02005432What this trial is testingPASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic RetinopathyWho this might be right forProliferative Diabetic Retinopathy University of Sao Paulo 31
Early research (Phase 1)Study completedNCT01968486What this trial is testingReduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic MyopiaWho this might be right forMyopia, Degenerative University of Campania Luigi Vanvitelli 60
Large-scale testing (Phase 3)Study completedNCT01217944What this trial is testingEfficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic MyopiaWho this might be right forPathological Myopia Novartis Pharmaceuticals 277
Testing effectiveness (Phase 2)UnknownNCT00100087What this trial is testingSafety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy SystemWho this might be right forMacular DegenerationChoroidal Neovascularization Theragenics Corporation 30
Testing effectiveness (Phase 2)Study completedNCT07550504What this trial is testingEvaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNVWho this might be right forAge-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular Edema+1 more Samsung Bioepis Co., Ltd. 30
Not applicableStudy completedNCT04470687What this trial is testingUltrafast Ultrasound Imaging Assesment of Carotid Plaque NeovascularizationWho this might be right forCarotid StenosisCarotid Artery DiseasesCarotid Atherosclerosis+2 more Assistance Publique - Hôpitaux de Paris 40
Testing effectiveness (Phase 2)Study completedNCT02014454What this trial is testingSafety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of PrematureWho this might be right forRetinopathy of Prematurity Meyer Children's Hospital IRCCS 23
Not applicableActive Not RecruitingNCT06597045What this trial is testingBIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORSWho this might be right forCancerCardiotoxicityAtherosclerotic Disease NHS Greater Glasgow and Clyde 60
Testing effectiveness (Phase 2)Study completedNCT00304954What this trial is testingInfliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationWho this might be right forAge-Related Macular DegenerationChoroidal Neovascularization National Eye Institute (NEI) 13
Testing effectiveness (Phase 2)UnknownNCT02934841What this trial is testingConbercept in Choroidal Neovascularization Secondary to UveitisWho this might be right forChoroidal NeovascularizationUveitis Chongqing Medical University 40
Not applicableEnded earlyNCT00272766What this trial is testingMacugen for HistoplasmosisWho this might be right forOcular HistoplasmosisChoroidal Neovascularization Barnes Retina Institute 24
Not applicableUnknownNCT02825277What this trial is testingUtero-placental Vascularisation in Normal and Preeclamptic and Intra-uterine Growth Restriction PregnanciesWho this might be right forPreeclampsiaIntra-uterine Growth Restriction Central Hospital, Nancy, France 112
Very early researchUnknownNCT05099094What this trial is testingVEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization DiseasesWho this might be right forNeovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion Shanghai BDgene Co., Ltd. 3
Post-approval studies (Phase 4)Ended earlyNCT01886794What this trial is testingHormonal Status on Blood Flow and Tissue in Pelvic Organ ProlapseWho this might be right forPelvic Floor Disorders The University of Texas Medical Branch, Galveston 7
Large-scale testing (Phase 3)UnknownNCT00438867What this trial is testingAngiogenesis in Women With Angina Pectoris Who Are Not Candidates for RevascularizationWho this might be right forAngina Pectoris Cardium Therapeutics 300